ACHV Achieve Life
- 4.750
- +0.020+0.42%
Achieve Life News
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
Achieve Life Sciences, Inc. (Nasdaq: ACHV) today announced publication of the ORCA-V1 trial results in the Journal of the American Medical Association (JAMA) Internal Medicine.
Achieve Life Sciences Files Prospectus Related To Offer & Sale From Time To Time Of Up To 13.1M Shares Of Common Stock, By Selling Stockholders
Achieve Life Sciences Files Prospectus Related To Offer & Sale From Time To Time Of Up To 13.1M Shares Of Common Stock, By Selling Stockholders
Jones Starts Achieve Life Sciences at Buy, Cites Market Opportunity
Achieve Life Sciences (ACHV.US) was first covered by JonesTrading, giving it a buy rating, with a target price of $20.00.
Achieve Life Sciences (ACHV.US) was first covered by JonesTrading, giving it a buy rating, with a target price of $20.00.
JonesTrading Initiates Coverage On Achieve Life Sciences With Buy Rating, Announces Price Target of $20
JonesTrading analyst Justin Walsh initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating and announces Price Target of $20.
Achieve Life Sciences: A Strong Buy for Tobacco Cessation Market Penetration
Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference
Achieve Life Sciences, Inc. (Nasdaq: ACHV) today announced that John Bencich, CEO of Achieve, will present at the Life Science Innovation Northwest (LSINW) 2024 Conference being held at the Seattle Convention Center April 17-18, 2024.
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2023 Earnings Call Transcript
Oppenheimer Reiterates Outperform on Achieve Life Sciences, Maintains $18 Price Target
Oppenheimer analyst Francois Brisebois reiterates Achieve Life Sciences (NASDAQ:ACHV) with a Outperform and maintains $18 price target.
Achieve Life Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/01/2024 286.27% Oppenheimer $18 → $18 Reiterates Outperform → Outperform 03/05/2024 136.05% Lake Street
Institutional Investors Own a Significant Stake of 36% in Achieve Life Sciences, Inc. (NASDAQ:ACHV)
Key Insights Institutions' substantial holdings in Achieve Life Sciences implies that they have significant influence over the company's share price The top 4 shareholders own 51% of the company
Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Phathom Pharmaceuticals (PHAT)
Earnings Call Summary | Achieve Life(ACHV.US) Q4 2023 Earnings Conference
The following is a summary of the Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript:Financial Performance:Achieve Life Sciences reported a decrease in cash, cash equivalents, and res
Achieve Life Sciences Inc Reports Year-End Loss, Progresses Towards FDA Approval
Recap: Achieve Life Sciences Q4 Earnings
Achieve Life Sciences (NASDAQ:ACHV) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:01 PM.Here's what investors need to know about the announcement.EarningsAchieve Life Sciences bea
Achieve Life Sciences GAAP EPS of -$0.26 Beats by $0.05
Press Release: Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update Company to host conference call at 4:30 PM EDT today, Thursday, March 28, 2024 SEAT
Achieve Life Sciences 4Q Loss/Shr 26c >ACHV
Achieve Life Sciences 4Q Loss/Shr 26c >ACHV
Calendar of U.S. Earnings Expected in the Week Ahead
Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc. Company Symbo
Earnings Scheduled For March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. • Shimmick (NASDAQ:SHIM) is estimated
Analysis
Price Target
No Data
